Nippon India Pharma Fund - Direct (Bonus) | |
---|---|
Summary Info | |
Fund Name | Nippon India Mutual Fund |
Scheme Name | Nippon India Pharma Fund - Direct (Bonus) |
AMC | Nippon India Mutual Fund |
Type | Open |
Category | Sectoral / Thematic |
Launch Date | 01-Jan-13 |
Fund Manager | Sailesh Raj Bhan |
Net Assets ( Cr.) | 8,914.89 |
NAV Graph | |||||
---|---|---|---|---|---|
One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Performance(%) | ||||||||
---|---|---|---|---|---|---|---|---|
1 Week[%] | 1 Month[%] | 3 Month[%] | 6 Month[%] | 1 Year[%] | 3 Year[%] | 5 Year[%] | Since INC[%] | |
Scheme Return | -2.57 | -1.62 | -4.34 | 7.56 | 24.59 | 19.03 | 27.19 | 18.67 |
Category Avg | -2.04 | -6.55 | -7.87 | -3.95 | 16.21 | 15.75 | 20.58 | 14.63 |
Category Best | 1.05 | -0.34 | 5.73 | 17.93 | 40.56 | 31.81 | 35.21 | 54.58 |
Category Worst | -5.90 | -12.36 | -15.65 | -20.66 | -3.68 | -1.72 | 2.03 | -13.07 |
Holdings | |
---|---|
Comapany Name | Hold % |
Sun Pharma.Inds. | 13.87 |
Divi's Lab. | 9.24 |
Lupin | 8.47 |
Dr Reddy's Labs | 5.70 |
Cipla | 5.32 |
Apollo Hospitals | 5.31 |
Vijaya Diagnost. | 3.59 |
Medplus Health | 3.32 |
Ajanta Pharma | 3.16 |
Gland Pharma | 2.99 |
Abbott India | 2.88 |
J B Chemicals & | 2.65 |
Aurobindo Pharma | 2.55 |
Mankind Pharma | 2.42 |
Zydus Lifesci. | 2.18 |
Narayana Hrudaya | 2.14 |
Glaxosmi. Pharma | 2.10 |
Torrent Pharma. | 1.90 |
Pfizer | 1.89 |
Fortis Health. | 1.86 |
Thyrocare Tech. | 1.81 |
Alkem Lab | 1.75 |
Sanofi India | 1.58 |
Orchid Pharma | 1.26 |
Suraksha Diagno. | 1.21 |
Sanofi Consumer | 1.18 |
Syngene Intl. | 1.08 |
Dr Lal Pathlabs | 0.97 |
Indoco Remedies | 0.68 |
Astrazeneca Phar | 0.53 |
Sai Life | 0.53 |
Emcure Pharma | 0.49 |
Health.Global | 0.49 |
Ipca Labs. | 0.45 |
Krishna Institu. | 0.31 |
Concord Biotech | 0.28 |
TREPS | 2.00 |
C C I | 0.01 |
Net CA & Others | -0.15 |